Pfizer's coronavirus vaccine could face some headwinds in the near future. The company will enter a period of patent cliffs ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer (NYSE: PFE) has been around for over 175 years, but it became a true household name during the COVID-19 pandemic as one of the main vaccine suppliers. That led to its stock price and revenue ...

The end date is what is known, in industry jargon, as a patent cliff. Essentially, when its patent ends, the revenue from a medication "falls off a cliff" as generic alternatives are introduced.

If you own or are considering buying pharma laggards Pfizer (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), and Merck (NYSE: ...

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to ...

The Vigo County History Center public exhibits display a fantastic representation of various aspects of local history. If you still haven’t seen it in person, I highly recommend you do. But for all ...

3SBio, a China partner of U.S. drug giant Pfizer, has reached agreements to raise approximately $400 million in a share ...

A list of high-quality dividend growth stocks is identified based on proximity to 52-week lows. Pfizer, Bristol-Myers Squibb, ResMed, and NextEra Energy appear attractively valued based on Future and ...

Pfizer possesses several qualities that make it attractive when market volatility is high. The stock has a low forward ...

A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated based on historical and future fair values. Pfizer's financial health is concerning, with unsustainable dividend ...